Table 1 Demographic and baseline characteristics of study population
All | HFEM | CM | |
|---|---|---|---|
N = 50 | n = 14 | n = 36 | |
Mean (SD) age, y | 43.2 (11.3) | 43.2 (12.3) | 43.3 (10.8) |
Female, n (%) | 40 (80) | 11 (78.6) | 29 (80.5) |
Mean (SD) disease duration, y | 29.7 (11.2) | 30.4 (13.5) | 29.5 (10.2) |
Mean (SD) number of migraine days per month | 15.4 (5.6) | 7.9 (2.3) | 18.3 (3.3) |
Allodyniaa, n (%) | 18 (36) | 4 (28.6) | 14 (38.9) |
Concomitant prophylaxis, n (%) | 39 (78) | 10 (71.4) | 29 (80.6) |
Migraine Type, n (%) | |||
Migraine without aura | 14 (28) | 14 (100) | 0 |
Medication overuse headache | 5 (10) | 0 | 5 (13.9) |
Chronic migraine | 36 (72) | 0 | 36 (100) |
Migraine Pain Location, n (%) | |||
Unilateral | 28 (56) | 10 (71.4) | 18 (50) |
Bilateral | 18 (36) | 3 (21.4) | 15 (41.7) |
Unilateral/bilateral | 4 (8) | 1 (7.2) | 3 (8.3) |
Duration of Migraine Attacks, n (%) | |||
≤24 h | 17 (34) | 5 (35.7) | 12 (33.3) |
25-48 h | 8 (16) | 2 (14.3) | 6 (16.7) |
>48 h | 25 (50) | 7 (50) | 18 (50) |